recombinant human thyroid-stimulating hormone

2 trials

Sponsors

Kanazawa University Hospital, Asahikawa Medical University

Conditions

Thyroid cancer

Unknown Phase

I-131 therapy for thyroid cancer with recombinant human thyroid-stimulating hormone (Thyrogen)

Active, not recruitingJPRN-UMIN000005692

Kanazawa University HospitalThyroid cancer

Start: 2011-01-01Target: 1Updated: 2026-06-29

I-131 therapy for metastatic thyroid cancer with recombinant human thyroid-stimulating hormone (Thyrogen)

Active, not recruitingJPRN-UMIN000013970

Asahikawa Medical UniversityThyroid cancer

Start: 2014-05-16Target: 10Updated: 2026-06-29